标题
PD-L1/PD-1 Axis in Glioblastoma Multiforme
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 21, Pages 5347
出版商
MDPI AG
发表日期
2019-10-28
DOI
10.3390/ijms20215347
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Obesity as a tumour development triggering factor
- (2019) Agnieszka Budny et al. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
- Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review
- (2019) Cezary Grochowski et al. MOLECULES
- Neural stem cell therapy - brief review
- (2018) Cezary Grochowski et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Monoclonal antibodies in cancer immunotherapy
- (2018) Ilgin Kimiz-Gebologlu et al. MOLECULAR BIOLOGY REPORTS
- EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
- (2017) Stefanie Keller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OS09.5 Synergistic effect of reirradiation and PD-1 inhibitors in recurrent high-grade gliomas
- (2017) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
- (2017) Manuela Silginer et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Ultra high field TOF-MRA: A method to visualize small cerebral vessels. 7 T TOF-MRA sequence parameters on different MRI scanners – Literature review
- (2017) Cezary Grochowski et al. Neurologia i Neurochirurgia Polska
- Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
- (2017) Song Xue et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Tumor microenvironment in treatment of glioma
- (2017) Guijie Li et al. Open Medicine
- Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
- (2016) Lucia Festino et al. DRUGS
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
- (2016) Kuti Baruch et al. NATURE MEDICINE
- ATIM-15. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN patients with recurrent high grade gliomas
- (2016) Solmaz Sahebjam et al. NEURO-ONCOLOGY
- Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
- (2016) Ju Yeon Lee et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
- (2016) Yang Yi et al. Frontiers in Pharmacology
- Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
- (2016) Marcel A. Deken et al. OncoImmunology
- Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
- (2015) Matthias Preusser et al. CLINICAL NEUROPATHOLOGY
- Immunotherapy for non-small cell lung cancer: current concepts and clinical trials
- (2015) Marissa Mayor et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- Mechanisms of action of therapeutic antibodies for cancer
- (2015) J.M. Redman et al. MOLECULAR IMMUNOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition
- (2015) Shanmugarajan Krishnan et al. Oncotarget
- Treatment of Elderly Patients With Glioblastoma
- (2015) Oren J. Zarnett et al. JAMA Neurology
- Immunotherapeutic Advancements for Glioblastoma
- (2015) Leonel Ampie et al. Frontiers in Oncology
- The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells
- (2015) Bo Yuan Huang et al. PLoS One
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Structure and Interactions of the Human Programmed Cell Death 1 Receptor
- (2013) Xiaoxiao Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) and immune response against infection: A systematic review
- (2013) Seyed Hossein Aalaei-andabili et al. JOURNAL OF INFECTION
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Inverse Association between Programmed Death Ligand 1 and Genes in the VEGF Pathway in Primary Clear Cell Renal Cell Carcinoma
- (2013) R. W. Joseph et al. Cancer Immunology Research
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- The regulation of cysteine cathepsins and cystatins in human gliomas
- (2012) Boris Gole et al. INTERNATIONAL JOURNAL OF CANCER
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells
- (2012) RYOSUKE ECHIGO et al. ONCOLOGY REPORTS
- Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma
- (2012) D Kesanakurti et al. Cell Death & Disease
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway
- (2011) M. Anand et al. JOURNAL OF NEURO-ONCOLOGY
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
- (2011) R Bonavia et al. ONCOGENE
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Cetuximab Insufficiently Inhibits Glioma Cell Growth Due to Persistent EGFR Downstream Signaling
- (2010) Benedikte Hasselbalch et al. CANCER INVESTIGATION
- Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
- (2010) Otto Haller et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes
- (2010) H.-W. Lo et al. MOLECULAR CANCER RESEARCH
- The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma
- (2010) Derek A. Wainwright et al. PLoS One
- Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
- (2009) J.-S. Guillamo et al. CLINICAL CANCER RESEARCH
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
- (2009) G. Karpel-Massler et al. MOLECULAR CANCER RESEARCH
- Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
- (2009) Allen Waziri NEUROSURGERY CLINICS OF NORTH AMERICA
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
- (2009) Haihao Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
- (2008) L. Verstrepen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression of TLR9 within human glioblastoma
- (2008) Yuxia Meng et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now